We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Dual Mobility Hip Implant Reduces Risk of Dislocation

By HospiMedica International staff writers
Posted on 19 Nov 2018
A new study shows that modular dual mobility (DM) hip implants could reduce the risk of dislocation in patients who need revision surgery.

Researchers at the Hospital for Special Surgery (HSS, New York, NY, USA) and other joint replacement centers in the United States conducted a study involving 370 patients (average 65.8 years of age) who underwent revision hip replacement with a DM implant between April 2011 and April 2017. More...
Clinical, radiographic, and patient reported-outcome information were collected for all patients; but to be included in the final report, patients needed to be seen for follow-up for at least two years after their surgery.

The results revealed that surgery with the DM implant resulted in a very low rate of instability for the revision patients (2.9%), with good functional improvement and a low rate of reoperation. According to the researchers, there was a clear benefit provided by the DM implant in the first few years following revision surgery. The study was presented at the annual meeting of the American Association of Hip and Knee Surgeons, held during November 2017 in Dallas (TX, USA).

“Although the concept of dual mobility was originally developed in France in the 1970s, the technology is relatively new in the United States,” said senior author Geoffrey Westrich, MD, research director of the adult reconstruction and joint replacement service at HSS. “Our study found that the newer technology with modular dual mobility components offered increased stability, lowering the risk of dislocation, without compromising hip range of motion in patients having a revision surgery.”

A hip replacement implant is a ball-and-socket mechanism, designed to simulate a human hip joint and mimic its movement. Typical components include a stem that inserts into the femur, a ball that replaces the head of the thighbone, and a shell that lines the hip socket. The concept of DM refers to the bearing surface of the implant; DM provide two areas of motion within the artificial socket, instead of one, thus improving the range of movement and reducing the risk of dislocation.

Related Links:
Hospital for Special Surgery


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.